Issledovaniâ i Praktika v Medicine (Jun 2015)
Resolution on the results of scientific-practical conference "Clinical evidence of increasing overall survival in the treatment of metastatic breast cancer", held on 29 November 2014 under the auspices of the Department of health of Moscow
- E. T. Bairamov,
- A. V. Belonogov,
- V. V. Brusnichkina,
- A. V. Bulakh,
- M. Y. Byahov,
- S. N. Gurov,
- G. G. Eremeev,
- N. V. Zhukov,
- L. G. Zhukova,
- L. M. Kogonia,
- P. V. Koposov,
- L. K. Ovchinnikova,
- V. V. Radlevich,
- E. A. Samyshina,
- A. P. Seryakov,
- M. D. Ter-Ovanesov,
- I. E. Shumskaya
Affiliations
- E. T. Bairamov
- SBME (CP No. 150) branch №4 of the City polyclinic №11, Moscow healthcare Department
- A. V. Belonogov
- SBM Oncological clinic №2 Moscow healthcare Department
- V. V. Brusnichkina
- SBM Oncological clinic №5 Moscow healthcare Department
- A. V. Bulakh
- SBM City Policlinics №201 Moscow Healthcare Department, branch №1
- M. Y. Byahov
- SBME «MCMC» Moscow Healthcare Department
- S. N. Gurov
- SBME Oncological clinic №1 Moscow Healthcare Department
- G. G. Eremeev
- SBM City Policlinics №8 Moscow Healthcare Department
- N. V. Zhukov
- SBME "Dmitriy Rogtachev FRCC CHOI" Moscow Healthcare Department
- L. G. Zhukova
- Federal State Scientific Institution "NN Blokhin Russian Cancer Research Center"
- L. M. Kogonia
- SBME M.F. Vladimirskiu Moscow regional research clinical Institute
- P. V. Koposov
- CC « European Medical Center»
- L. K. Ovchinnikova
- SMH MROC, Balashika
- V. V. Radlevich
- SBM Oncological clinic №2 Moscow healthcare Department
- E. A. Samyshina
- SBM Oncological clinic №4 Moscow healthcare Department
- A. P. Seryakov
- SMH MROC, Balashika
- M. D. Ter-Ovanesov
- SBM State City clinic №40 Moscow healthcare Department
- I. E. Shumskaya
- SBME branch №3 (CP № 68) of City Policlinics №117 Moscow healthcare Department
- Journal volume & issue
-
Vol. 2,
no. 2
pp. 102 – 104
Abstract
Objectives: discussion of modern treatment options for metastatic breast cancer (MBC), the determining of the optimal treatment for subgroups of patients with poor prognosis.
